Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131 I‑Labeling and SPECT Imaging.
- Resource Type
- Article
- Source
- Molecular Pharmaceutics; 3/6/2023, Vol. 20 Issue 3, p1750-1757, 8p
- Subject
- Language
- ISSN
- 15438384